Articles from Earflo

Earflo, a medical technology company developing a non-invasive, at-home treatment for negative middle ear pressure in children as young as two, today announced a $415,000 social-mission investment from the Richard King Mellon Foundation. The funds will support FDA clearance, manufacturing, and launch preparation efforts to bring Earflo’s at-home solution to families.

Earflo, a medical technology company developing a non-invasive, at-home treatment for negative middle ear pressure in children as young as two, today announced it has been named a CES Innovation Awards® Best of Innovation in Digital Health. Earflo demonstrated exceptional innovation in design and engineering, earning the highest evaluation scores within the Digital Health category from an elite panel of industry expert judges.